AnnouncementsJubilant Life Sciences: Board recommends dividend
75% of moneycontrol users recommend buying Jubilant Life.
What's your call on Jubilant Life today?
Read Investor view
|Company Name||Last Price||%
|Dr Reddys Labs||2826.25||-0.43||2939.80||2128.40||48,140.94|
|Mar' 14||Dec' 13||Sep' 13||Jun' 13|
IFGL Refractories Recommended on May 28th 2014
Recommended price 114.00 | Peak from reco 201.00 76.01%
What are Multi baggers?
Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.
Jubilant Life is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 2,726.10 crore.The company has reported a consolidated sales of Rs 1,460.53 crore and a Net Profit of Rs 9.38 crore for the quarter ended Jun 2014.
The company management includes Shyam S Bhartia - Chairman & Managing Director, Hari S Bhartia - Co-Chairman & Manag. Director, Shyamsundar Bang - Executive Director, Sudha Pillai - Director, Abhay Havaldar - Director, Shardul S Shroff - Director, Inder Mohan Verma - Director, Suresh Kumar - Director, S Sridhar - Director.
It is listed on the BSE with a BSE Code of 530019 and the NSE with an NSE Code of JUBILANT.
Its Registered office is at Bhartiagram, Gajraula,, Amroha District,Uttar Pradesh - 244223.
Their Registrars are Alankit Assignment Ltd.